Unknown

Dataset Information

0

HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts.


ABSTRACT: BACKGROUND:Cryptococcal meningitis can occur in persons with less-apparent immunosuppression. We evaluated clinical characteristics and outcomes of persons with HIV-related Cryptococcus presenting with higher CD4 counts. METHODS:We enrolled 736 participants from 2 prospective cohorts in Uganda and South Africa from November 2010 to May 2017. We compared participants with CD4 <50, 50-99, or ?100 cells/?L by clinical characteristics, cerebrospinal fluid (CSF) parameters, and 18-week survival. RESULTS:Among first episode of cryptococcosis, 9% presented with CD4 ?100 cells/?L. Participants with CD4 ?100 cells/?L presented more often with altered mental status (52% vs 39%; P = .03) despite a 10-fold lower initial median CSF fungal burden of 7850 (interquartile range [IQR] 860-65500) versus 79000 (IQR 7400-380000) colony forming units/mL (P < .001). Participants with CD4 ?100 cells/?L had higher median CSF levels of interferon-gamma, interleukin (IL)-6, IL-8, and IL-13, and lower monocyte chemokine, CCL2 (P < .01 for each). Death within 18 weeks occurred in 47% with CD4 <50, 35% with CD4 50-99, and 40% with CD4 ?100 cells/?L (P = .04). CONCLUSION:HIV-infected individuals developing cryptococcal meningitis with CD4 ?100 cells/?L presented more frequently with altered mental status despite having 10-fold lower fungal burden and with greater Th2 (IL-13) immune response. Higher CD4 count was protective despite an increased propensity for immune-mediated damage, consistent with damage-response framework. CLINICAL TRIAL REGISTRATION:NCT01075152 and NCT01802385.

SUBMITTER: Tugume L 

PROVIDER: S-EPMC6387427 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Cryptococcal meningitis can occur in persons with less-apparent immunosuppression. We evaluated clinical characteristics and outcomes of persons with HIV-related Cryptococcus presenting with higher CD4 counts.<h4>Methods</h4>We enrolled 736 participants from 2 prospective cohorts in Uganda and South Africa from November 2010 to May 2017. We compared participants with CD4 <50, 50-99, or ≥100 cells/μL by clinical characteristics, cerebrospinal fluid (CSF) parameters, and 18-week  ...[more]

Similar Datasets

| S-EPMC4778268 | biostudies-literature
| S-EPMC6312212 | biostudies-literature
| S-EPMC5371305 | biostudies-literature
2021-03-01 | GSE162914 | GEO
| S-EPMC10024640 | biostudies-literature
| S-EPMC5818156 | biostudies-literature
| S-EPMC3654748 | biostudies-literature
| S-EPMC9219642 | biostudies-literature
| S-EPMC4447450 | biostudies-literature
| S-EPMC3716603 | biostudies-literature